Archivo Eventos

The role of OSM cytokine in cancer metabolism and immunesuppression

Currently there are not efficient therapies with curative intent for advanced breast cancer (BC). In particular, advanced triple negative (TN) BC has poor prognosis and lacks targeted therapies. Therefore, finding new strategies for those cases is an unmet need with high clinical impact. In this context, the pro-inflammatory cytokine Oncostatin

Leer más »
08/07/22

Cognoscenti Tissue Engineering & Regenerative Medicine

.

+ Info

01/07/22

ALTEN: a high-fidelity tumouroid 3D culture platform for next-generation personalised medicine

.

+ Info

27/06/22

CANCELADO/ Uda Ikastaroa / Curso de Verano UPV-EHU: ¿Podemos prevenir la obesidad infanto-juvenil?

.

+ Info

24/06/22

“Your Next Generation ELISA”

.

+ Info

24/06/22

In vitro diagnostics and Cancer Therapeutics: challenges & opportunities

.

+ Info

17/06/22

Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

.

+ Info

16/06/22

Uda Ikastaroa / Curso de Verano UPV-EHU: Terapias avanzadas: del laboratorio al paciente y a la sociedad

.

+ Info

10/06/22

New predictive biomarkers of endocrine therapy in oestrogen receptor–positive breast cancer

.

+ Info

30/05/22

From Single Cell to Spatial Transcriptomics: biology at true resolution

.

+ Info

24/05/22

Inmunoterapia Celular en el Trasplante de Progenitores

.

+ Info